about
P1037
Fetal exposure to teratogens: evidence of genes involved in autismD2 receptor imaging in neonates using I-123 iodobenzamide brain SPECT.Polyunsaturated fatty acids and cerebral function: focus on monoaminergic neurotransmission.DPA-714, a new translocator protein-specific ligand: synthesis, radiofluorination, and pharmacologic characterization.Design of α7 nicotinic acetylcholine receptor ligands in quinuclidine, tropane and quinazoline series. Chemistry, molecular modeling, radiochemistry, in vitro and in rats evaluations of a [(18)F] quinuclidine derivative.Time-course of nigrostriatal degeneration in a progressive MPTP-lesioned macaque model of Parkinson's disease.[11C]MADAM Used as a Model for Understanding the Radiometabolism of Diphenyl Sulfide Radioligands for Positron Emission Tomography (PET).Design of α7 nicotinic acetylcholine receptor ligands using the (het)Aryl-1,2,3-triazole core: Synthesis, in vitro evaluation and SAR studies.Evaluation of a 3D local multiresolution algorithm for the correction of partial volume effects in positron emission tomography.PET radioligands for the vesicular acetylcholine transporter (VAChT).PET tracers for imaging brain α7 nicotinic receptors: an update.PiB-Conjugated, Metal-Based Imaging Probes: Multimodal Approaches for the Visualization of β-Amyloid Plaques.Presymptomatic diagnosis of experimental Parkinsonism with 123I-PE2I SPECT.Protection of dopaminergic nigrostriatal afferents by GDNF delivered by microspheres in a rodent model of Parkinson's disease.Assessment of the Protection of Dopaminergic Neurons by an α7 Nicotinic Receptor Agonist, PHA 543613 Using [(18)F]LBT-999 in a Parkinson's Disease Rat Model.Effects of translocator protein (18 kDa) ligands on microglial activation and neuronal death in the quinolinic-acid-injected rat striatum.Serotoninergic neurotransmission is affected by n-3 polyunsaturated fatty acids in the rat.Longitudinal and parallel monitoring of neuroinflammation and neurodegeneration in a 6-hydroxydopamine rat model of Parkinson's disease.Evaluation of prion deposits and microglial activation in scrapie-infected mice using molecular imaging probes.Behavior and serotonergic disorders in rats exposed prenatally to valproate: a model for autism.Synthesis of tropane and nortropane analogues with phenyl substitutions as serotonin transporter ligands.mRNA D(2) dopaminergic receptor expression after hypoxia-ischemia in rat immature brain.Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease.Neither the density nor function of striatal dopamine transporters were influenced by chronic n-3 polyunsaturated fatty acid deficiency in rodents.Relevance of different striatal markers in assessment of the MPP+-induced dopaminergic nigrostriatal injury in rat.Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease.Reversibility of n-3 fatty acid deficiency-induced changes in dopaminergic neurotransmission in rats: critical role of developmental stage.Motor behaviour deficits and their histopathological and functional correlates in the nigrostriatal system of dopamine transporter knockout mice.Ontogeny of the dopamine and serotonin transporters in the rat brain: an autoradiographic study.Involvement of alpha6/alpha3 neuronal nicotinic acetylcholine receptors in neuropsychiatric features of Dementia with Lewy bodies: [(125)I]-alpha-conotoxin MII binding in the thalamus and striatum.Cholinergic nicotinic receptor involvement in movement disorders associated with Lewy body diseases. An autoradiography study using [(125)I]alpha-conotoxinMII in the striatum and thalamus.Initial evaluation in healthy humans of [18F]DPA-714, a potential PET biomarker for neuroinflammation.Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) exposure induces long-term alterations in the dopaminergic and serotonergic functions in the rat.Neuroprotection of nerve growth factor-loaded microspheres on the D2 dopaminergic receptor positive-striatal neurones in quinolinic acid-lesioned rats: a quantitative autoradiographic assessment with iodobenzamide.[18F]FDDNP performed better than [18F] Florbetapir to distinguish transthyretin cardiac amyloidosis (TTR-CA) patients from healthy controls: an ex vivo study.Synthesis, radiolabeling and preliminary in vivo evaluation of [18F]FE-PE2I, a new probe for the dopamine transporter.In vitro autoradiography and in vivo evaluation in cynomolgus monkey of [18F]FE-PE2I, a new dopamine transporter PET radioligand.Guideline to regulations for radiopharmaceuticals in early phase clinical trials in the EU.Evaluation of CLINDE as potent translocator protein (18 kDa) SPECT radiotracer reflecting the degree of neuroinflammation in a rat model of microglial activation.IMPY, a potential beta-amyloid imaging probe for detection of prion deposits in scrapie-infected mice.
P50
Q28302087-232F70F5-8921-4058-8D3C-977AEC497191Q31804886-7FB3AE14-05C6-4191-B68B-BA784D7D2D44Q34449751-224F474B-115C-4E63-9B70-02CB60524760Q34769959-0C31AB3C-9A09-46EC-A4A9-2469334B1358Q35182746-57D77494-F822-4ACC-B7EB-0B8D787F2A66Q35622290-AA2793A8-C75D-42CE-AB17-4066966FCC03Q35772756-C59C9EA4-A81D-471E-83C3-D5716409BE67Q35845376-B4B5A1F6-B42A-47AA-87C3-8FEE9F2B9D84Q36360240-8ABD08F6-7CA5-45FD-B7CE-A3E0B115B7BDQ37768198-928DD789-B15F-4842-B28B-C92E99276335Q38584762-864E103E-F6F8-4235-A781-284D2E90CA0EQ39780926-D3D22515-EF6E-463B-A0D5-0D055AF0400FQ40572605-4A2A2A79-D534-4DB9-BD76-D7F266735096Q40738171-C1096FEF-15A8-408D-A931-45C7EBEE7B16Q41778722-5A3136F7-657C-4840-99F8-84F81114B136Q41964688-3A6FA3AD-6357-4323-BC6E-F45A9388082DQ42460253-1B1C2444-AE7C-4E19-8F0D-D8EBA12323C4Q42502183-F22860C0-DD91-4221-8F16-AB20A38B1E07Q43106374-BCA0C4BA-D873-4064-B66D-4A6DD0B64D9BQ43207009-1DB4F0F3-5CB2-4561-81CB-57F9BF906C00Q43653180-AB88C06A-019B-4E7B-91F3-C4FDCD74EBADQ43688666-41E971FA-6B0E-4FB6-A1F3-6AA73DA72AD0Q43715960-007E3859-9507-4540-9664-A898BC5AFD8EQ43901323-E03A9621-CBF1-490A-A2FD-F3E80586EB62Q43924709-A06A7149-FE72-44E9-BA75-8FA708F91881Q44095653-3719B5C1-59E2-4B69-A332-DCD2177E3E75Q44102338-8E93AEC0-F421-4D03-BCCD-08F17E5A1887Q44345639-96724AFF-586F-4D00-957E-7A6B51216342Q44925873-796E0EB9-A5B8-46F0-A499-5EAD3B5BF32CQ45149613-42240480-EBEA-4900-A787-0F2EB61CCEF7Q45223153-2B257EC5-83B0-4622-9430-8CDD50DB4AD8Q45245938-D0C8885C-77DD-49C0-8AA7-9185FFE3CDF0Q45262394-91F676AB-EAEB-4768-9417-4666CE08F055Q45300665-4E8C450A-3CF6-41D6-8C40-86D5EC8EDE3DQ45851589-8D485B43-0E68-4DC7-8B6A-D8DBB647D7D5Q45939976-3A8BD91A-A914-4E02-81E4-E77C7059DF61Q45948467-E2962700-445F-49E8-BCFD-0BC7B5C102BCQ46438337-AEAD56D0-E3A4-4A1E-86A2-72F6CB4F981EQ46553768-3649FF2E-AD04-43BA-B41A-746E21909D12Q46723803-7C6866F7-3CB5-4B5C-BB8B-88A1635449CF
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Denis Guilloteau
@ast
Denis Guilloteau
@en
Denis Guilloteau
@es
Denis Guilloteau
@nl
Denis Guilloteau
@sl
type
label
Denis Guilloteau
@ast
Denis Guilloteau
@en
Denis Guilloteau
@es
Denis Guilloteau
@nl
Denis Guilloteau
@sl
prefLabel
Denis Guilloteau
@ast
Denis Guilloteau
@en
Denis Guilloteau
@es
Denis Guilloteau
@nl
Denis Guilloteau
@sl
P106
P21
P31
P3762
P496
0000-0002-4545-3068